Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 332

    Orchid Pharma gets EIR from USFDA for its Chennai facility

    Orchid Pharma gets EIR from USFDA for its Chennai facility

    Ruby Khatun Khatun9 Jan 2018 11:00 AM IST
    New Delhi: Drug firm Orchid Pharma said it has received Establishment Inspection Report (EIR) from the US health regulator for its Chennai...
    Supreme Court favours 85 percent pictorial warning on tobacco packs

    Supreme Court favours 85 percent pictorial warning on tobacco packs

    Ruby Khatun Khatun9 Jan 2018 10:30 AM IST
    New Delhi: The Supreme Court on Monday stayed the Karnataka High Court's order that had quashed the rule for 85 percent pictorial warning on tobacco...
    Sanofi to market new hemophilia drug in deal with Alnylam

    Sanofi to market new hemophilia drug in deal with Alnylam

    Ruby Khatun Khatun9 Jan 2018 10:15 AM IST
    PARIS: French pharmaceutical group Sanofi said it has obtained the right to develop and sell a new hemophilia drug in a restructuring of its...
    Novo Nordisk offers 3.1 billion dollars for Belgian biotech group Ablynx

    Novo Nordisk offers 3.1 billion dollars for Belgian biotech group Ablynx

    Ruby Khatun Khatun9 Jan 2018 10:00 AM IST
    BRUSSELS: Danish drugmaker Novo Nordisk said on Monday it had made a 2.6 billion euros ($3.12 billion) bid for Belgian biotech group Ablynx, the...
    Siemens to list Healthineers unit in March: sources

    Siemens to list Healthineers unit in March: sources

    Ruby Khatun Khatun9 Jan 2018 9:30 AM IST
    MUNICH: Siemens plans to list its 40 billion euro ($48 billion) healthcare unit Healthineers in March, two people close to the matter said, as the...
    Patanjali plans massive online push

    Patanjali plans massive online push

    Ruby Khatun Khatun8 Jan 2018 10:45 AM IST
    New Delhi: Baba Ramdev-led Patanjali Ayurved is likely to partner with eight leading retailers and aggregators to give a big push to online sales of...
    Pfizer ends research for new Alzheimers, Parkinsons drugs

    Pfizer ends research for new Alzheimer's, Parkinson's drugs

    Ruby Khatun Khatun8 Jan 2018 10:30 AM IST
    NEW YORK: Pfizer Inc is abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease, the U.S. pharmaceutical company...
    Five healthcare startups to watch out for in 2018

    Five healthcare startups to watch out for in 2018

    Ruby Khatun Khatun8 Jan 2018 10:15 AM IST
    New Delhi: Healthcare has become India's one of the largest sectors - both in terms of revenue and employment. Healthcare is an industry with the...
    Alphabet healthcare gets 20.8 million dollars funding to help Medicaid patients

    Alphabet healthcare gets 20.8 million dollars funding to help Medicaid patients

    Ruby Khatun Khatun8 Jan 2018 10:00 AM IST
    Cityblock Health, a healthcare company which aims to serve low-income urban residents covered by Medicaid and Medicare, said it received $20.8 million...
    FDA expands use of Amgens blockbuster drug

    FDA expands use of Amgen's blockbuster drug

    Ruby Khatun Khatun8 Jan 2018 9:45 AM IST
    Amgen Inc said that the U.S. Food and Drug Administration approved its drug, Xgeva, to prevent fractures in patients with multiple myeloma.Xgeva has...
    Mallinckrodt completes Stannsoporfin new drug application filing

    Mallinckrodt completes Stannsoporfin new drug application filing

    Ruby Khatun Khatun8 Jan 2018 9:30 AM IST
    Mallinckrodt plc announced it has successfully completed the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug...
    40 complaints regarding stent overpricing received: Govt

    40 complaints regarding stent overpricing received: Govt

    Ruby Khatun Khatun7 Jan 2018 11:00 AM IST
    New Delhi: Drug pricing regulator NPPA has received a total of 40 complaints so far for overpricing of coronary stents by hospitals, Parliament was...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok